TDOC:CA:TSX-TD Global Healthcare Leaders Index ETF (CAD)

ETF | Others |

Last Closing

CAD 18.89

Change

+0.06 (+0.32)%

Market Cap

CAD 0.09B

Volume

4.25K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.09 (+0.34%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

+0.39 (+1.15%)

CAD 6.03B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.57B
PHYS-U:CA Sprott Physical Gold Trust

-0.07 (-0.33%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.33 (+0.88%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.25 (+0.55%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.27 (-1.07%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.16 (-1.55%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.19 (+0.85%)

CAD 2.78B

ETFs Containing TDOC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.89% 80% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.89% 80% B- 73% C
Trailing 12 Months  
Capital Gain 5.89% 33% F 36% F
Dividend Return 2.52% 46% F 33% F
Total Return 8.41% 31% F 33% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.32% 52% F 45% F
Dividend Return 3.46% 50% F 39% F
Total Return 0.14% 29% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 6.09% 75% C 88% B+
Risk Adjusted Return 56.81% 72% C 68% D+
Market Capitalization 0.09B 61% D- 32% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.